CLRB logo

Cellectar Biosciences (CLRB) EBITDA

Annual EBITDA

-$38.77 M
-$10.10 M-35.24%

December 31, 2023


Summary


Performance

CLRB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

Quarterly EBITDA

-$13.26 M
+$378.60 K+2.78%

September 30, 2024


Summary


Performance

CLRB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

TTM EBITDA

-$51.29 M
-$3.89 M-8.20%

September 30, 2024


Summary


Performance

CLRB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLRB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.2%-6.3%-32.3%
3 y3 years-155.9%-129.3%-134.6%
5 y5 years-235.0%-237.4%-265.1%

CLRB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-61.7%at low-125.3%+2.8%-115.9%at low
5 y5-year-176.0%at low-295.6%+2.8%-265.1%at low
alltimeall time-1412.6%at low-3655.1%+2.8%<-9999.0%at low

Cellectar Biosciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.26 M(-2.8%)
-$51.29 M(+8.2%)
Jun 2024
-
-$13.64 M(+14.5%)
-$47.40 M(+12.8%)
Mar 2024
-
-$11.91 M(-4.5%)
-$42.02 M(+8.4%)
Dec 2023
-$38.77 M(+35.2%)
-$12.48 M(+33.1%)
-$38.77 M(+15.1%)
Sep 2023
-
-$9.37 M(+13.5%)
-$33.67 M(+5.0%)
Jun 2023
-
-$8.26 M(-4.7%)
-$32.09 M(+2.7%)
Mar 2023
-
-$8.66 M(+17.3%)
-$31.23 M(+9.0%)
Dec 2022
-$28.67 M(+19.5%)
-$7.38 M(-5.1%)
-$28.67 M(+5.5%)
Sep 2022
-
-$7.78 M(+5.1%)
-$27.16 M(+7.9%)
Jun 2022
-
-$7.40 M(+21.4%)
-$25.17 M(+5.9%)
Mar 2022
-
-$6.10 M(+3.6%)
-$23.75 M(-0.9%)
Dec 2021
-$23.98 M(+58.3%)
-$5.88 M(+1.7%)
-$23.98 M(+9.7%)
Sep 2021
-
-$5.78 M(-3.5%)
-$21.86 M(+9.6%)
Jun 2021
-
-$5.99 M(-5.3%)
-$19.95 M(+13.7%)
Mar 2021
-
-$6.32 M(+68.0%)
-$17.55 M(+15.8%)
Dec 2020
-$15.15 M(+7.9%)
-$3.76 M(-2.8%)
-$15.15 M(+2.8%)
Sep 2020
-
-$3.87 M(+8.0%)
-$14.74 M(-0.4%)
Jun 2020
-
-$3.59 M(-8.6%)
-$14.79 M(+2.9%)
Mar 2020
-
-$3.92 M(+17.1%)
-$14.37 M(+2.3%)
Dec 2019
-$14.05 M(+21.4%)
-$3.35 M(-14.7%)
-$14.05 M(+9.1%)
Sep 2019
-
-$3.93 M(+24.1%)
-$12.87 M(+7.1%)
Jun 2019
-
-$3.17 M(-12.0%)
-$12.01 M(+2.4%)
Mar 2019
-
-$3.60 M(+65.2%)
-$11.73 M(+1.4%)
Dec 2018
-$11.57 M(-4.0%)
-$2.18 M(-29.1%)
-$11.57 M(-5.4%)
Sep 2018
-
-$3.07 M(+6.4%)
-$12.23 M(-2.4%)
Jun 2018
-
-$2.89 M(-16.0%)
-$12.54 M(-1.8%)
Mar 2018
-
-$3.44 M(+21.1%)
-$12.77 M(+5.9%)
Dec 2017
-$12.05 M(+32.6%)
-$2.84 M(-16.0%)
-$12.05 M(+2.3%)
Sep 2017
-
-$3.38 M(+8.4%)
-$11.78 M(+9.3%)
Jun 2017
-
-$3.12 M(+14.3%)
-$10.78 M(+8.8%)
Mar 2017
-
-$2.73 M(+6.4%)
-$9.91 M(+9.0%)
Dec 2016
-$9.09 M(+11.0%)
-$2.56 M(+7.6%)
-$9.09 M(+10.8%)
Sep 2016
-
-$2.38 M(+6.1%)
-$8.20 M(+6.1%)
Jun 2016
-
-$2.24 M(+17.4%)
-$7.74 M(+1.7%)
Mar 2016
-
-$1.91 M(+14.2%)
-$7.60 M(-7.2%)
Dec 2015
-$8.19 M(-11.9%)
-$1.67 M(-12.5%)
-$8.19 M(-5.7%)
Sep 2015
-
-$1.91 M(-9.4%)
-$8.68 M(-3.0%)
Jun 2015
-
-$2.11 M(-15.5%)
-$8.95 M(-1.5%)
Mar 2015
-
-$2.50 M(+15.4%)
-$9.09 M(-2.2%)
DateAnnualQuarterlyTTM
Dec 2014
-$9.30 M(-14.5%)
-$2.16 M(-0.9%)
-$9.30 M(-7.0%)
Sep 2014
-
-$2.18 M(-2.9%)
-$10.00 M(-5.8%)
Jun 2014
-
-$2.25 M(-16.9%)
-$10.62 M(-3.3%)
Mar 2014
-
-$2.71 M(-5.4%)
-$10.99 M(+1.0%)
Dec 2013
-$10.88 M(+31.8%)
-$2.86 M(+2.0%)
-$10.88 M(+8.0%)
Sep 2013
-
-$2.80 M(+7.3%)
-$10.07 M(+9.4%)
Jun 2013
-
-$2.61 M(+0.5%)
-$9.20 M(+5.9%)
Mar 2013
-
-$2.60 M(+26.8%)
-$8.69 M(+4.6%)
Dec 2012
-$8.26 M(+23.7%)
-$2.05 M(+5.9%)
-$8.30 M(-8.7%)
Sep 2012
-
-$1.94 M(-7.9%)
-$9.09 M(+1.9%)
Jun 2012
-
-$2.10 M(-5.1%)
-$8.92 M(+5.8%)
Mar 2012
-
-$2.22 M(-22.0%)
-$8.43 M(+26.3%)
Dec 2011
-$6.67 M(+87.4%)
-$2.84 M(+61.2%)
-$6.67 M(+58.9%)
Sep 2011
-
-$1.76 M(+9.3%)
-$4.20 M(+44.8%)
Jun 2011
-
-$1.61 M(+251.2%)
-$2.90 M(+13.6%)
Mar 2011
-
-$459.00 K(+25.5%)
-$2.55 M(-44.7%)
Dec 2010
-$3.56 M(-64.9%)
-$365.60 K(-21.0%)
-$4.61 M(-41.0%)
Sep 2010
-
-$462.90 K(-63.4%)
-$7.82 M(-19.0%)
Jun 2010
-
-$1.27 M(-49.8%)
-$9.64 M(-7.6%)
Mar 2010
-
-$2.52 M(-29.3%)
-$10.43 M(+2.9%)
Dec 2009
-$10.13 M(-38.9%)
-$3.57 M(+55.7%)
-$10.13 M(+16.3%)
Sep 2009
-
-$2.29 M(+11.6%)
-$8.71 M(-2.9%)
Jun 2009
-
-$2.05 M(-7.6%)
-$8.97 M(-22.9%)
Mar 2009
-
-$2.22 M(+3.7%)
-$11.63 M(-29.8%)
Dec 2008
-$16.57 M(-18.3%)
-$2.14 M(-16.0%)
-$16.57 M(-21.5%)
Sep 2008
-
-$2.55 M(-45.8%)
-$21.12 M(-16.2%)
Jun 2008
-
-$4.71 M(-34.2%)
-$25.21 M(+1.1%)
Mar 2008
-
-$7.16 M(+7.1%)
-$24.93 M(+22.9%)
Dec 2007
-$20.28 M(+127.3%)
-$6.69 M(+0.7%)
-$20.28 M(+23.5%)
Sep 2007
-
-$6.64 M(+49.8%)
-$16.43 M(+28.6%)
Jun 2007
-
-$4.43 M(+76.4%)
-$12.78 M(+27.8%)
Mar 2007
-
-$2.51 M(-11.4%)
-$10.00 M(+12.1%)
Dec 2006
-$8.92 M(+248.0%)
-$2.84 M(-5.2%)
-$8.92 M(+30.7%)
Sep 2006
-
-$2.99 M(+80.6%)
-$6.83 M(+42.4%)
Jun 2006
-
-$1.66 M(+15.7%)
-$4.79 M(+31.6%)
Mar 2006
-
-$1.43 M(+92.4%)
-$3.64 M(+42.1%)
Dec 2005
-$2.56 M
-$744.60 K(-22.4%)
-$2.56 M(+40.9%)
Sep 2005
-
-$959.70 K(+89.7%)
-$1.82 M(+111.7%)
Jun 2005
-
-$506.00 K(+43.3%)
-$859.10 K(+143.3%)
Mar 2005
-
-$353.10 K
-$353.10 K

FAQ

  • What is Cellectar Biosciences annual EBITDA?
  • What is the all time high annual EBITDA for Cellectar Biosciences?
  • What is Cellectar Biosciences annual EBITDA year-on-year change?
  • What is Cellectar Biosciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cellectar Biosciences?
  • What is Cellectar Biosciences quarterly EBITDA year-on-year change?
  • What is Cellectar Biosciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Cellectar Biosciences?
  • What is Cellectar Biosciences TTM EBITDA year-on-year change?

What is Cellectar Biosciences annual EBITDA?

The current annual EBITDA of CLRB is -$38.77 M

What is the all time high annual EBITDA for Cellectar Biosciences?

Cellectar Biosciences all-time high annual EBITDA is -$2.56 M

What is Cellectar Biosciences annual EBITDA year-on-year change?

Over the past year, CLRB annual EBITDA has changed by -$10.10 M (-35.24%)

What is Cellectar Biosciences quarterly EBITDA?

The current quarterly EBITDA of CLRB is -$13.26 M

What is the all time high quarterly EBITDA for Cellectar Biosciences?

Cellectar Biosciences all-time high quarterly EBITDA is -$353.10 K

What is Cellectar Biosciences quarterly EBITDA year-on-year change?

Over the past year, CLRB quarterly EBITDA has changed by -$781.20 K (-6.26%)

What is Cellectar Biosciences TTM EBITDA?

The current TTM EBITDA of CLRB is -$51.29 M

What is the all time high TTM EBITDA for Cellectar Biosciences?

Cellectar Biosciences all-time high TTM EBITDA is -$353.10 K

What is Cellectar Biosciences TTM EBITDA year-on-year change?

Over the past year, CLRB TTM EBITDA has changed by -$12.52 M (-32.29%)